Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Metabolife Liability Reversal Offers Precedent For Ephedra Defendants

Mar 14 2005

• By The Tan Sheet

Related Content

Metabolife 356 “Unreasonably Dangerous,” Jury Says In $4.1 Mil. Verdict

Nov 25 2002

Additional Topics

OTC Drugs Consumer

More from Archive

More from HBW Insight

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window